Amazing Presentation at Investment Conference with Acquisition Plans for Clinics Generating $100 Million in 2025 to Complement Drug Development for Bipolar Depression & Related Disorders: NRXP -The Globe and Mail theglobeandmail.com/investing/mark… #PharmaNews #bipolar #NRX100 #NRX101 $NRXP
NRx Pharmaceuticals Presents at Investment Conference with Acquisition Plans for Clinics Generating $100 Million in 2025 to Complement Drug Development for Bipolar Depression & Related Disorders -Boston Herald markets.financialcontent.com/bostonherald/a… #PharmaNews #NRX100 #NRX101 $NRXP
Substantial Funding, Debt Resolution, HOPE Dividend, Successful Clinical Trial Towards Accelerated Drug Approval for Bipolar Depression: NRx Pharmaceuticals, Inc. (Nasdaq: $NRXP) Read More - markets.financialcontent.com/bostonherald/a… #PharmaNews #ketamine #stress #PTSD #bipolar #NRX100 #NRX101